Cargando…
Effectiveness of suvorexant versus benzodiazepine receptor agonist sleep drugs in reducing the risk of hip fracture: Findings from a regional population-based cohort study
Sleep drugs are often necessary to treat insomnia in older patients. Benzodiazepine receptor agonists (BZRAs) are primarily used for insomnia in these patients, but there are concerns regarding their association with delirium and bone fractures. Among sleep drugs, orexin receptor antagonists such as...
Autores principales: | Yoshioka, Ryozo, Yamamoto, Seiichiro, Nakatani, Eiji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10124872/ https://www.ncbi.nlm.nih.gov/pubmed/37093840 http://dx.doi.org/10.1371/journal.pone.0284726 |
Ejemplares similares
-
Assessment of Switching to Suvorexant versus the Use of Add-on Suvorexant in Combination with Benzodiazepine Receptor Agonists in Insomnia Patients: A Retrospective Study
por: Hatano, Masakazu, et al.
Publicado: (2018) -
Distinct effects of IPSU and suvorexant on mouse sleep architecture
por: Hoyer, Daniel, et al.
Publicado: (2013) -
Suvorexant improves intractable nocturnal enuresis by altering sleep architecture
por: Matsumoto, Tohru
Publicado: (2021) -
Profile of suvorexant in the management of insomnia
por: Sutton, Eliza L
Publicado: (2015) -
Single-use suvorexant for treating insomnia during overnight polysomnography in patients with suspected obstructive sleep apnea: a single-center experience
por: Matsumura, Takuma, et al.
Publicado: (2019)